{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(1)"],"submitter":["Kischel P"],"pubmed_abstract":["Hodgkin lymphoma (HL) represents a category of lymphoid neoplasms with unique features, notably the usual scarcity of tumour cells in involved tissues. The most common subtype of classical HL, nodular sclerosis HL, characteristically comprises abundant fibrous tissue stroma. Little information is available about the protein composition of the stromal environment from HL. Moreover, the identification of valid protein targets, specifically and abundantly expressed in HL, would be of utmost importance for targeted therapies and imaging, yet the biomarkers must necessarily be accessible from the bloodstream. To characterize HL stroma and to identify potentially accessible proteins, we used a chemical proteomic approach, consisting in the labelling of accessible proteins and their subsequent pu"],"journal":["Proteome science"],"pagination":["63"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3200160"],"repository":["biostudies-literature"],"pubmed_title":["Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma."],"pmcid":["PMC3200160"],"pubmed_authors":["de Leval L","Mazzucchelli G","Waltregny D","Greffe Y","Castronovo V","De Pauw E","Kischel P"],"additional_accession":[]},"is_claimable":false,"name":"Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma.","description":"Hodgkin lymphoma (HL) represents a category of lymphoid neoplasms with unique features, notably the usual scarcity of tumour cells in involved tissues. The most common subtype of classical HL, nodular sclerosis HL, characteristically comprises abundant fibrous tissue stroma. Little information is available about the protein composition of the stromal environment from HL. Moreover, the identification of valid protein targets, specifically and abundantly expressed in HL, would be of utmost importance for targeted therapies and imaging, yet the biomarkers must necessarily be accessible from the bloodstream. To characterize HL stroma and to identify potentially accessible proteins, we used a chemical proteomic approach, consisting in the labelling of accessible proteins and their subsequent pu","dates":{"release":"2011-01-01T00:00:00Z","publication":"2011 Oct","modification":"2026-04-08T02:45:28.654Z","creation":"2019-03-27T00:45:20Z"},"accession":"S-EPMC3200160","cross_references":{"pubmed":["21975223"],"doi":["10.1186/1477-5956-9-63"]}}